Browse By: Country ι Category ι Tag
Home  »  Non Small Cell Lung Cancer

Non Small Cell Lung Cancer Market Research Reports

More

Non-Small Cell Lung Cancer - Pipeline Review, H2 2016
Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non-Small Cell Lung Cancer – Pipeline Review, H2 2016, provides an overview of the Non-Small Cell Lung Cancer (Oncology) pipeline landscape. Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. NSCLC is a cancer (malignancy) that originates in the tissues of the lungs or the cells lining the airways. Symptoms of lung cancer usually occur in later stages of the disease. The signs and symptoms include persistent cough that may get worse over time, trouble breathing or shortness of breath, constant chest pain or discomfort, bloody phlegm or spit (sputum), fatigue and weakness and unintentional weight loss. The disease might be controlled with the help of medications, chemoth
Published Date: Dec 2016
Published By: Global Markets Direct

Price: $2500
United States Non Small Cell Lung Cancer Therapeutics Industry 2016 Market Research Report
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Non Small Cell Lung Cancer Therapeutics market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact info
Published Date: Jun 2016
Published By: QYResearch

Price: $3800
Global Non Small Cell Lung Cancer Therapeutics Consumption 2016 Market Research Report
First, the report provides a basic overview of the Non Small Cell Lung Cancer Therapeutics industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures. Secondly, the report states the global Non Small Cell Lung Cancer Therapeutics market size (volume and value), and the segment markets by regions, types, applications and companies are also discussed. Third, the Non Small Cell Lung Cancer Therapeutics market analysis is provided for major regions including USA, Europe, China and Japan, and other regions can be added. For each region, market size and end users are analyzed as well as segment markets by types, applications and companies. Then, the report focu
Published Date: Jun 2016
Published By: QYResearch

Price: $4000
Gemzar (Non Small Cell Lung Cancer) Analysis and Forecasts to 2015
GlobalDatas pharmaceuticals report, Gemzar (Non Small Cell Lung Cancer) - Analysis and Forecasts to 2015 provides Gemzar sales forecasts for the US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002- 2015). The report also includes information on Non Small Cell Lung Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData\'s team of industry experts.
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Tarceva (Non Small Cell Lung Cancer) Analysis and Forecasts to 2015
GlobalDatas pharmaceuticals report, Tarceva (Non Small Cell Lung Cancer) - Analysis and Forecasts to 2020 provides Tarceva sales forecasts for the US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2004-2020). The report also includes information on Non Small Cell Lung Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData\'s team of industry experts
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Vargatef (Non Small Cell Lung Cancer) Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Vargatef (Non Small Cell Lung Cancer) - Analysis and Forecasts to 2020 provides Vargatef sales forecasts for the US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2015-2020). The report also includes information on Non Small Cell Lung Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData\'s team of industry exper
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Cisplatin (Non Small Cell Lung Cancer) Analysis and forecasts to 2020
GlobalDatas pharmaceuticals report, Cisplatin (Non Small Cell Lung Cancer) - Analysis and Estimates from 2002 to 2020 provides cisplatin sales estimates for the US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Non Small Cell Lung Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData\'s team of in
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Abraxane (Non Small Cell Lung Cancer) Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Abraxane (Non Small Cell Lung Cancer) - Analysis and Forecasts to 2020 provides abraxane sales forecasts for the US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2013-2020). The report also includes information on Non Small Cell Lung Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData\'s team of industry exper
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
ARQ 197 (Non Small Cell Lung Cancer) Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, ARQ 197 (Non Small Cell Lung Cancer) - Analysis and Forecasts to 2020 provides ARQ 197 sales forecasts for the US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2015-2020). The report also includes information on Non Small Cell Lung Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData\'s team of industry experts
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Opaxio (Non Small Cell Lung Cancer) Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Opaxio (Non Small Cell Lung Cancer) - Analysis and Forecasts to 2020 provides Opaxio sales forecasts for the US. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2015-2020). The report also includes information on Non Small Cell Lung Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData\'s team of industry experts. Note:
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Etoposide (Non Small Cell Lung Cancer) Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Etoposide (Non Small Cell Lung Cancer)- Analysis and Forecasts to 2020 provides Etoposide sales forecasts for the US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Non Small Cell Lung Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData\'s team of industry expe
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Talactoferrin Alfa (Non Small Cell Lung Cancer) Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Talactoferrin Alfa (Non Small Cell Lung Cancer)- Analysis and Forecasts to 2020 provides Talactoferrin Alfa sales forecasts for the US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Non Small Cell Lung Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData\
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Alimta (Non Small Cell Lung Cancer) Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Alimta (Non Small Cell Lung Cancer)- Analysis and Forecasts to 2020 provides Alimta sales forecasts for the US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2004-2020). The report also includes information on Non Small Cell Lung Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData\'s team of industry experts.
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Stimuvax (Non Small Cell Lung Cancer) Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Stimuvax (Non Small Cell Lung Cancer)- Analysis and Forecasts to 2020 provides Stimuvax sales forecasts for the US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2012-2020). The report also includes information on Non Small Cell Lung Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData\'s team of industry
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Taxol (Non Small Cell Lung Cancer) Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Taxol (Non Small Cell Lung Cancer)- Analysis and Forecasts to 2020 provides Taxol sales forecasts for the US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2017). The report also includes information on Non Small Cell Lung Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData\'s team of industry experts.
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Afatinib (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Afatinib (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020 provides Afatinib sales forecasts for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2013-2020). The report also includes information on Non Small Cell Lung Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData\'s team of industry experts.
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Taxotere (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Taxotere (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020 provides Taxotere\'s sales forecasts for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Non Small Cell Lung Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData\'s team of industry expert
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Avastin (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Avastin (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020 provides Avastin sales Forecasts for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2006-2020). The report also includes information on Non-Small Cellular Lung Cancer. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData\'s team of industry experts. Note
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Crizotinib (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Crizotinib (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020 provides Crizotinib sales forecasts for US. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2013-2020). The report also includes information on Non-Small Cell Lung Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData\'s team of industry experts. Note: This
Published Date: Oct 2011
Published By: GlobalData

Price: $2000
Iressa (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020
GlobalDatas pharmaceuticals report, Iressa (Non Small Cell Lung Cancer)-Analysis and Forecasts to 2020 provides Crizotinib salesforecasts for US. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Non-Small Cell Lung Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData\'s team of industry experts. Note: Thi
Published Date: Oct 2011
Published By: GlobalData

Price: $2000

Back To Top